Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)
- Status
- COMPLETED
- Phase
- PHASE3
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Cardiac Safety Study in Patients With HER2 + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
- Status
- TERMINATED
- Phase
- NA
Real World Efficiency of Trastuzumab in Early Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
- Status
- COMPLETED
- Phase
- PHASE2
NSABP Biospecimen Discovery Project
- Status
- UNKNOWN
- Phase
- N/A
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
- Status
- COMPLETED
- Phase
- N/A
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2